Business Description
PharmAust Ltd
NAICS : 325412
SIC : 2834
ISIN : AU000000PAA1
Compare
Compare
Traded in other countries / regions
PAA.AustraliaECQ.Germany IPO Date
2001-10-05Description
PharmAust Ltd operates as a drug discovery and development company in Australia, Switzerland, and internationally. It develops drug discovery intellectual property for the treatment of various cancers in humans and animals. The company offers Monepantel and Albendazole, which are in Phase II clinical trials for the treatment of cancer. It also provides medicinal and synthetic chemistry services on a contract basis to the drug discovery and pharmaceutical industries.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.2 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -0.13 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | 9.98 | |||||
| Beneish M-Score | -4.24 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -6.5 | |||||
| 3-Year EBITDA Growth Rate | -81.7 | |||||
| 3-Year EPS without NRI Growth Rate | -17 | |||||
| 3-Year FCF Growth Rate | -7.7 | |||||
| 3-Year Book Growth Rate | -26.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.32 | |||||
| 9-Day RSI | 27.86 | |||||
| 14-Day RSI | 34.19 | |||||
| 6-1 Month Momentum % | 371.83 | |||||
| 12-1 Month Momentum % | 235 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.55 | |||||
| Quick Ratio | 4.55 | |||||
| Cash Ratio | 4.44 | |||||
| Days Inventory | 630.05 | |||||
| Days Sales Outstanding | 128.76 | |||||
| Days Payable | 600.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.8 | |||||
| Shareholder Yield % | -2.91 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.9 | |||||
| Operating Margin % | -552.48 | |||||
| Net Margin % | -723.76 | |||||
| FCF Margin % | -168.87 | |||||
| ROE % | -103.43 | |||||
| ROA % | -79.42 | |||||
| ROIC % | -109.89 | |||||
| ROC (Joel Greenblatt) % | -697.82 | |||||
| ROCE % | -122.33 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 120 | |||||
| PB Ratio | 12 | |||||
| Price-to-Tangible-Book | 24 | |||||
| EV-to-EBIT | -10.91 | |||||
| EV-to-EBITDA | -11.12 | |||||
| EV-to-Revenue | 102.47 | |||||
| EV-to-FCF | -60.68 | |||||
| Price-to-Median-PS-Value | 4 | |||||
| Price-to-Net-Current-Asset-Value | 24 | |||||
| Price-to-Net-Cash | 24 | |||||
| Earnings Yield (Greenblatt) % | -9.17 | |||||
| FCF Yield % | -1.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PharmAust Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.909 | ||
| EPS (TTM) (A$) | -0.019 | ||
| Beta | 1.65 | ||
| Volatility % | 113.48 | ||
| 14-Day RSI | 34.19 | ||
| 14-Day ATR (A$) | 0.02892 | ||
| 20-Day SMA (A$) | 0.33425 | ||
| 12-1 Month Momentum % | 235 | ||
| 52-Week Range (A$) | 0.0655 - 0.535 | ||
| Shares Outstanding (Mil) | 395.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PharmAust Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PharmAust Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
PharmAust Ltd Frequently Asked Questions
What is PharmAust Ltd(ASX:PAA)'s stock price today?
The current price of ASX:PAA is A$0.24. The 52 week high of ASX:PAA is A$0.54 and 52 week low is A$0.07.
When is next earnings date of PharmAust Ltd(ASX:PAA)?
The next earnings date of PharmAust Ltd(ASX:PAA) is .
Does PharmAust Ltd(ASX:PAA) pay dividends? If so, how much?
PharmAust Ltd(ASX:PAA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers